← All Sponsors
SPONSOR

St. Jude Children's Research Hospital

Total Trials
16
Recruiting
16
Phases
Phase 1, Phase 2

St. Jude Children's Research Hospital is a clinical research sponsor with 16 registered studies on ClinicalTrials.gov, of which 16 are actively recruiting participants. Research covers conditions including Sickle Cell Disease, Cancer, Fluid Overload, Executive Dysfunction.

The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — St. Jude Children's Research Hospital

How many clinical trials has St. Jude Children's Research Hospital sponsored?
ClinicalMetric currently tracks 16 clinical trials sponsored by St. Jude Children's Research Hospital, of which 16 are actively recruiting participants. These trials cover conditions including Sickle Cell Disease, Cancer, Fluid Overload. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does St. Jude Children's Research Hospital research focus on?
St. Jude Children's Research Hospital clinical trials span Sickle Cell Disease, Cancer, Fluid Overload, Executive Dysfunction, Cognitive Impairment, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a St. Jude Children's Research Hospital clinical trial?
To participate in a St. Jude Children's Research Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all St. Jude Children's Research Hospital trials with current recruitment status updated daily.

Clinical Trials by St. Jude Children's Research Hospital

NCT07392216
Recruiting

Functional Ovarian Reserve in Sickle Cell Disease

Sickle Cell Disease
NCT00760656
Recruiting

Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer

Cancer
NCT07834710
Recruiting

Using Bioimpedance Analysis to Monitor Fluid Status in Children

Fluid Overload
NCT07226219 Phase 1
Recruiting

Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease

Sickle Cell Disease
NCT03050268
Recruiting

Familial Investigations of Childhood Cancer Predisposition

Acute Leukemia
NCT05955261 Phase 2
Recruiting

A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia
NCT06477289
Recruiting

Peripheral Arterial Tonometry and Neurocognition in Sickle Cell Disease

Sickle Cell Disease
NCT05664126 Phase 2
Recruiting

Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation

Cytomegalovirus
NCT00684580
Recruiting

Protocol For Collecting Data On Patients With Childhood Cancer

Childhood Cancer
NCT07675083
Recruiting

Bereaved Parent Conversations on Hope

Hope
NCT06506461 Phase 1
Recruiting

Gene Editing For Sickle Cell Disease

Sickle Cell Disease
NCT02530658
Recruiting

Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

Solid, Liquid, Central Nervous System Tumors
NCT00730678
Recruiting

Pharmacogenetic Determinants Of Treatment Response In Children

All Malignancies
NCT06442761 Phase 1
Recruiting

SCD Stem Cell Mobilization and Apheresis Using Motixafortide

Sickle Cell Disease
NCT07314736
Recruiting

Stakeholders of Rare Diseases Informing Values In Neuroethics

Rare Disorder
NCT06023641 Phase 2
Recruiting

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

Rhabdomyosarcoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology